Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Oxygen therapy study on heart nerves ends early

NCT ID NCT07537452

Knowledge-focused Sponsor: Assaf-Harofeh Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how breathing pure oxygen in a high-pressure chamber (hyperbaric oxygen therapy) changes the body's automatic heart control in people with neurological injury. Researchers planned to measure heart rate variability in 17 patients before and after treatment. The study was terminated early, so results are limited.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
100% oxygen in a hyperbaric chamber

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

17 people

The number who actually took part.

Started

Aug 2018

Finished

Jul 2020

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who are scheduled to receive a series of treatments at a pressure cell at Assaf Harofeh Hospital

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients who are scheduled to receive a series of treatments at a pressure cell at Assaf Harofeh Hospital and are willing to participate in the study. Exclusion Criteria: * Patients who received previous hyperbaric oxygen therapy for any reason during the 6 months prior to inclusion. * A history of malignancy during the last year of inclusion. * A pulmonary disease that does not allow the patient to be admitted to a pressure cell (severe emphysema, moderate obstruction) . * patients that unable to sign informed consent form.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neurological injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

nervous system injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neurological injury

Contacts and locations

Locations

  • hyperbaric center Asaf harofe medical center

    Rishon LeZiyyon, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.